Kalaria R N, Grahovac I
Department of Neurology, Case Western Reserve University School of Medicine, Cleveland, OH 44106.
Brain Res. 1990 May 21;516(2):349-53. doi: 10.1016/0006-8993(90)90941-4.
Serum amyloid P (SAP) has been shown to be consistently present in all types of amyloid deposits except cerebral lesions of neurofibrillary tangles and senile plaques. We used immunohistochemical methods to demonstrate SAP reactivity in both tangles and plaques, as well as vessels, in lightly fixed frozen tissue sections of hippocampus and parahippocampal gyrus from subjects with Alzheimer's disease (AD) and normal controls. As confirmed by thioflavin S staining, heavy deposition of immunoperoxidase reaction product was evident in Sommer's sector (CA1), the subiculum and entorhinal cortex with both the antisera to SAP used. Serial sections immunostained with antiserum to amyloid A or preimmune rabbit serum showed no evidence for staining in plaques or tangles. These observations provide evidence for extravasation of the protein across the blood-brain barrier (BBB) in disease although expression of it by cellular elements within or entering the brain through the BBB cannot be ruled out. Our results also implicate the use of lightly fixed tissue for localization of some antigens by immunohistochemistry in postmortem human brain.
血清淀粉样蛋白P(SAP)已被证明始终存在于除神经原纤维缠结和老年斑的脑病变外的所有类型淀粉样沉积物中。我们使用免疫组织化学方法在患有阿尔茨海默病(AD)的受试者和正常对照的海马体和海马旁回轻度固定冰冻组织切片中的缠结、斑块以及血管中显示SAP反应性。经硫黄素S染色证实,使用的两种抗血清在 Sommer 区(CA1)、海马下脚和内嗅皮质中免疫过氧化物酶反应产物大量沉积。用抗淀粉样蛋白A抗血清或免疫前兔血清免疫染色的连续切片在斑块或缠结中未显示染色证据。这些观察结果为疾病中该蛋白穿过血脑屏障(BBB)外渗提供了证据,尽管不能排除通过BBB进入脑内或脑内细胞成分对其的表达。我们的结果还表明,在死后人类大脑中通过免疫组织化学定位某些抗原时,使用轻度固定的组织是有必要的。